Cross-sectional associations between dietary intake and carotid intima media thickness in type 2 diabetes: baseline data from a randomised trial

Laura Chiavaroli, Arash Mirrahimi, Christopher Ireland, Sandra Mitchell, Sandhya Sahye-Pudaruth, Judy Coveney, Omodele Olowoyeye, Darshna Patel, Russell J de Souza, Livia S A Augustin, Balachandran Bashyam, Sathish Chandra Pichika, Sonia Blanco Mejia, Stephanie K Nishi, Lawrence A Leiter, Robert G Josse, Gail E McKeown-Eyssen, Alan R Moody, Cyril W C Kendall, John L Sievenpiper, David J A Jenkins, Laura Chiavaroli, Arash Mirrahimi, Christopher Ireland, Sandra Mitchell, Sandhya Sahye-Pudaruth, Judy Coveney, Omodele Olowoyeye, Darshna Patel, Russell J de Souza, Livia S A Augustin, Balachandran Bashyam, Sathish Chandra Pichika, Sonia Blanco Mejia, Stephanie K Nishi, Lawrence A Leiter, Robert G Josse, Gail E McKeown-Eyssen, Alan R Moody, Cyril W C Kendall, John L Sievenpiper, David J A Jenkins

Abstract

Objective: To assess associations between dietary intake and carotid intima media thickness (CIMT) by carotid ultrasound (CUS), a surrogate marker of cardiovascular disease (CVD) risk, in those with type 2 diabetes.

Design: Cross-sectional analysis of baseline data from 325 participants from three randomised controlled trials collected in the same way.

Setting: Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada.

Participants: 325 participants with type 2 diabetes, taking oral antidiabetic agents, with an HbA1c between 6.5% and 8.0% at screening, without a recent cardiovascular event.

Main outcome measures: CIMT by CUS and associations with dietary intake from 7-day food records, as well as anthropometric measures and fasting serum samples.

Results: CIMT was significantly inversely associated with dietary pulse intake (β=-0.019, p=0.009), available carbohydrate (β=-0.004, p=0.008), glycaemic load (β=-0.001, p=0.007) and starch (β=-0.126, p=0.010), and directly associated with total (β=0.004, p=0.028) and saturated (β=0.012, p=0.006) fat intake in multivariate regression models adjusted for age, smoking, previous CVD event, blood pressure medication, antidiabetic medication and ultrasonographer.

Conclusions: Lower CIMT was significantly associated with greater consumption of dietary pulses and carbohydrates and lower total and saturated fat intake, suggesting a potential role for diet in CVD risk management in type 2 diabetes. Randomised controlled trials are anticipated to explore these associations further.

Trial registration number: NCT01063374.

Keywords: DIABETES & ENDOCRINOLOGY; NUTRITION & DIETETICS.

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare the following: LC has received research support from the Canadian Institutes of Health Research (CIHR). LC is a clinical research coordinator at Glycaemic Index Laboratories, Toronto, Ontario, Canada. RJdS is funded by a Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship Award and has received research support from the CIHR, the Calorie Control Council, the Canadian Foundation for Dietetic Research, and The Coca-Cola Company (investigator initiated, unrestricted grant). RJdS has served as an external resource person to the World Health Organization's Nutrition Guidelines Advisory Group on trans fats, saturated fats, and polyunsaturated fats. The WHO paid for his travel and accommodation to attend meetings from 2012–2016 to present and discuss this work. He has also done contract research for the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism, and Diabetes, Health Canada, and the World Health Organization for which he received remuneration. He has held a grant from the Canadian Foundation for Dietetic Research as a principal investigator, and is a co-investigator on several funded team grants from Canadian Institutes of Health Research. RJdS received compensation for a lecture on dietary fat given at McMaster Pediatric Nutrition Days in 2016. LSAA has received an honorarium from the Nutrition Foundation of Italy (NFI) to co-organize a glycaemic index summit. ARM is currently consultant for Jansen/Johnson and Johnson. JLS has received research support from the Canadian Institutes of health Research (CIHR), Canadian Diabetes Association (CDA), PSI Foundation, Calorie Control Council, Banting and Best Diabetes Centre (BBDC), American Society for Nutrition (ASN), INC International Nut and Dried Fruit Council Foundation, National Dried Fruit Trade Association, The Coca-Cola Company (investigator initiated, unrestricted), Dr. Pepper Snapple Group (investigator initiated, unrestricted), and The Tate and Lyle Nutritional Research Fund at the University of Toronto. He has received speaker fees and/or honoraria from the Canadian Diabetes Association (CDA), Canadian Nutrition Society (CNS), University of Alabama at Birmingham, Dr. Pepper Snapple Group, Dairy Farmers of Canada, Nutrition Foundation of Italy (NFI), C3 Collaborating for Health, Sprim Brasil, WhiteWave Foods, Rippe Lifestyle, mdBriefcase, Alberta Milk, FoodMinds LLC, Memac Ogilvy & Mather LLC, PepsiCo, and Pulse Canada. He has ad hoc consulting arrangements with Winston & Strawn LLP, Perkins Coie LLP, and Tate & Lyle. He is a member of the European Fruit Juice Association Scientific Expert Panel. He is on the Clinical Practice Guidelines Expert Committees of the Canadian Diabetes Association (CDA), European Association for the study of Diabetes (EASD), and Canadian Cardiovascular Society (CCS), as well as an expert writing panel of the American Society for Nutrition (ASN). He serves as an unpaid scientific advisor for the Food, Nutrition, and Safety Program (FNSP) and the Technical Committee on Carbohydrates of the International Life Science Institute (ILSI) North America. He is a member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the EASD, and Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. His wife is an employee of Unilever Canada. CWCK has received research grants, travel funding, consultant fees, honoraria, or has served on the scientific advisory board for Abbott Laboratories, Advanced Food Materials Network, Agriculture and Agri-Food Canada (AAFC), Almond Board of California, American Peanut Council, American Pistachio Growers, Barilla, Bayer, California Strawberry Commission, Calorie Control Council, Canadian Institutes of Health Research (CIHR), Canola Council of Canada, The Coca-Cola Company, Danone, General Mills, Hain Celestial, International Nut and Dried Fruit Council, International Tree Nut Council Nutrition Research and Education Foundation, Kellogg, Kraft, Loblaw Brands, Nutrition Foundation of Italy, Oldways Preservation Trust, Orafti, Paramount Farms, Peanut Institute, PepsiCo, Pulse Canada, Sabra Dipping Co., Saskatchewan Pulse Growers, Solae, Sun-Maid, Tate & Lyle, Unilever and White Wave Foods. He is on the Dietary Guidelines Committee for the Diabetes Nutrition Study Group of the European Association for the Study of Diabetes. DJAJ has received research grants from Saskatchewan Pulse Growers, the Agricultural Bioproducts Innovation Program through the Pulse Research Network, the Advanced Foods and Material Network, Loblaw Companies, Unilever, Barilla, the Almond Board of California, Agriculture and Agri-Food Canada, Pulse Canada, Kellogg's Company, Canada, Quaker Oats, Canada, Procter & Gamble Technical Centre ., Bayer Consumer Care, Springfield, NJ, Pepsi/Quaker, International Nut and Dried Fruit, Soy Foods Association of North America, the Coca-Cola Company (investigator initiated, unrestricted grant), Solae, Haine Celestial, the Sanitarium Company, Orafti, the International Tree Nut Council Nutrition Research and Education Foundation, the Peanut Institute, the Canola and Flax Councils of Canada, the Calorie Control Council (CCC), the CIHR, the Canada Foundation for Innovation and the Ontario Research Fund. He has been on the speaker's panel, served on the scientific advisory board and/or received travel support and/or honoraria from the Almond Board of California, Canadian Agriculture Policy Institute, Loblaw Companies, the Griffin Hospital (for the development of the NuVal scoring system, the Coca-Cola Company, EPICURE, Danone, Diet Quality Photo Navigation (DQPN), Saskatchewan Pulse Growers, Sanitarium Company, Orafti, the Almond Board of California, the American Peanut Council, the International Tree Nut Council Nutrition Research and Education Foundation, the Peanut Institute, Herbalife International, Pacific Health Laboratories, Nutritional Fundamental for Health, Barilla, Metagenics, Bayer Consumer Care, Unilever Canada and the Netherlands, Solae, Kellogg, Quaker Oats, Procter & Gamble, the Coca-Cola Company, the Griffin Hospital, Abbott Laboratories, the Canola Council of Canada, Dean Foods, the California Strawberry Commission, Haine Celestial, PepsiCo, the Alpro Foundation, Pioneer Hi-Bred International, DuPont Nutrition and Health, Spherix Consulting and WhiteWave Foods, the Advanced Foods and Material Network, the Canola and Flax Councils of Canada, the Nutritional Fundamentals for Health, AgriCulture and Agri-Food Canada, the Canadian Agri-Food Policy Institute, Pulse Canada, the Saskatchewan Pulse Growers, the Soy Foods Association of North America, the Nutrition Foundation of Italy (NFI), Nutrasource Diagnostics, the McDougall Program, the Toronto Knowledge Translation Group (St. Michael's Hospital), the Canadian College of Naturopathic Medicine, The Hospital for Sick Children, the Canadian Nutrition Society (CNS), the American Society of Nutrition (ASN), Arizona State University, Paolo Sorbini Foundation and the Institute of Nutrition, Metabolism and Diabetes. He received an honorarium from the US Department of Agriculture to present the 2013 W.O. Atwater Memorial Lecture. He received the 2013 Award for Excellence in Research from the International Nut and Dried Fruit Council. He received funding and travel support from the Canadian Society of Endocrinology and Metabolism to produce mini cases for the Canadian Diabetes Association (CDA). He is a member of the International Carbohydrate Quality Consortium (ICQC). His wife, ALJ, is a director and partner of Glycaemic Index Laboratories, and his sister received funding through a grant from the St. Michael's Hospital Foundation to develop a cookbook for one of his studies. AM, SM, SSP, JC, DP, OO, SBM, BB, SCP, LAL, RGJ and GM have no relevant conflicts of interest to declare.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Figures

Figure 1
Figure 1
Model of association between dietary pulse intake and carotid intima media thickness (CIMT). The multivariate regression model is adjusted for age, smoking, previous cardiovascular disease (CVD) event, blood pressure medication, antidiabetic medication and ultrasonographer.

References

    1. Mozaffarian D, Benjamin EJ, Go AS et al. . Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 2015;131:e29–322. 10.1161/CIR.0000000000000152
    1. Shah AD, Langenberg C, Rapsomaniki E et al. . Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol 2015;3:105–13. 10.1016/S2213-8587(14)70219-0
    1. Perk J, De Backer G, Gohlke H et al. . European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635–701. 10.1093/eurheartj/ehs092
    1. Greenland P, Alpert JS, Beller GA et al. . 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:e50–103. 10.1016/j.jacc.2010.09.001
    1. Yoshida M, Mita T, Yamamoto R et al. . Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care 2012;35:178–80. 10.2337/dc11-1333
    1. Lorenz MW, Markus HS, Bots ML et al. . Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459–67. 10.1161/CIRCULATIONAHA.106.628875
    1. Mostaza JM, Lahoz C, Salinero-Fort MA et al. . Carotid atherosclerosis severity in relation to glycemic status: a cross-sectional population study. Atherosclerosis 2015;242:377–82. 10.1016/j.atherosclerosis.2015.07.028
    1. Marini MA, Succurro E, Castaldo E et al. . Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care 2012;35:1144–9. 10.2337/dc11-2032
    1. Bobbert T, Mai K, Fischer-Rosinsky A et al. . A1C is associated with intima-media thickness in individuals with normal glucose tolerance. Diabetes Care 2010;33:203–4. 10.2337/dc09-1009
    1. Esposito K, Giugliano D, Nappo F et al. . Campanian Postprandial Hyperglycemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004;110:214–9. 10.1161/01.CIR.0000134501.57864.66
    1. Mita T, Katakami N, Yoshii H et al. . Alogliptin, a dipeptidyl peptidase 4 inhibitor, prevents the progression of carotid atherosclerosis in patients with type 2 diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139–48. 10.2337/dc15-0781
    1. Sidhu JS, Kaposzta Z, Markus HS et al. . Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscler Thromb Vasc Biol 2004;24:930–4. 10.1161/01.ATV.0000124890.40436.77
    1. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457–71. 10.1056/NEJMoa072761
    1. Hanefeld M, Chiasson JL, Koehler C et al. . Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 2004;35:1073–8. 10.1161/01.STR.0000125864.01546.f2
    1. Yun P, Du AM, Chen XJ et al. . Effect of acarbose on long-term prognosis in acute coronary syndromes patients with newly diagnosed impaired glucose tolerance. J Diabetes Res 2016;2016:1602083 10.1155/2016/1602083
    1. Murie-Fernandez M, Irimia P, Toledo E et al. . Carotid intima-media thickness changes with Mediterranean diet: a randomized trial (PREDIMED-Navarra). Atherosclerosis 2011;219:158–62. 10.1016/j.atherosclerosis.2011.06.050
    1. Ma XY, Liu JP, Song ZY. Glycemic load, glycemic index and risk of cardiovascular diseases: meta-analyses of prospective studies. Atherosclerosis 2012;223:491–6. 10.1016/j.atherosclerosis.2012.05.028
    1. Mirrahimi A, de Souza RJ, Chiavaroli L et al. . Associations of glycemic index and load with coronary heart disease events: a systematic review and meta-analysis of prospective cohorts. J Am Heart Assoc 2012;1:e000752 10.1161/JAHA.112.000752
    1. Nouri F, Sarrafzadegan N, Mohammadifard N et al. . Intake of legumes and the risk of cardiovascular disease: frailty modeling of a prospective cohort study in the Iranian middle-aged and older population. Eur J Clin Nutr 2016;70:217–21. 10.1038/ejcn.2015.153
    1. Bazzano LA, He J, Ogden LG et al. . Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med 2001;161:2573–8. 10.1001/archinte.161.21.2573
    1. Rodriguez-Monforte M, Flores-Mateo G, Sanchez E. Dietary patterns and CVD: a systematic review and meta-analysis of observational studies. Br J Nutr 2015;114:1341–59. 10.1017/S0007114515003177
    1. Chiavaroli L, Mirrahimi A, Ireland C et al. . Low-glycaemic index diet to improve glycaemic control and cardiovascular disease in type 2 diabetes: design and methods for a randomised, controlled, clinical trial. BMJ Open 2016;6:e012220 10.1136/bmjopen-2016-012220
    1. Jenkins DJ, Kendall CW, Augustin LS et al. . Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med 2012;172:1653–60. 10.1001/2013.jamainternmed.70
    1. Jenkins DJ, Kendall CW, Vuksan V et al. . Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial. Diabetes Care 2014;37:1806–14. 10.2337/dc13-2990
    1. Pitt B, Byington RP, Furberg CD et al. . Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000;102:1503–10. 10.1161/01.CIR.102.13.1503
    1. Riley WA, Barnes RW, Applegate WB et al. . Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The asymptomatic carotid artery plaque study. Stroke 1992;23:1062–8.
    1. Dogan S, Duivenvoorden R, Grobbee DE et al. . Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia. Ann Med 2010;42: 447–64. 10.3109/07853890.2010.499132
    1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
    1. US Department of Agriculture. Composition of foods, agriculture handbook No. 23: The agriculture research service. Washington, DC: US Dept of Agriculture, 2010.
    1. Canadian Nutrient File. .
    1. Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care 2008;31:2281–3. 10.2337/dc08-1239
    1. Diabetes Care. doi: 10.2337/dc11-0338. Salas-Salvadó J, Bulló M, Babio N, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. 2011;34:14–9.
    1. Jenkins DJ, Srichaikul K, Kendall CW et al. . The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes. Diabetologia 2011;54:271–9. 10.1007/s00125-010-1927-1
    1. Tobacco Free Initiative (TFI). Fact sheet about health benefits of smoking cessation 2016. (accessed 20 Jan 2016).
    1. Monami M, Genovese S, Mannucci E. Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials. Diabetes Obes Metab 2013;15:938–53. 10.1111/dom.12116
    1. Rosen CJ. The rosiglitazone story--lessons from an FDA Advisory Committee meeting. N Engl J Med 2007;357:844–6. 10.1056/NEJMp078167
    1. D'Agostino RB Sr, Vasan RS, Pencina MJ et al. . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743–53. 10.1161/CIRCULATIONAHA.107.699579
    1. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc 1964;26:211–34.
    1. Health Canada. Eating well with Canada’s food guide. 2011. Retrieved from .
    1. Goff LM, Cowland DE, Hooper L et al. . Low glycaemic index diets and blood lipids: a systematic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 2013;23:1–10. 10.1016/j.numecd.2012.06.002
    1. Buyken AE, Goletzke J, Joslowski G et al. . Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies. Am J Clin Nutr 2014;99:813–33. 10.3945/ajcn.113.074252
    1. Rajabi S, Mazloom Z, Zamani A et al. . Effect of low glycemic index diet versus metformin on metabolic syndrome. Int J Endocrinol Metab 2015;13:e23091 10.5812/ijem.23091
    1. Chiasson JL, Josse RG, Gomis R et al. . Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003;290:486–94. 10.1001/jama.290.4.486
    1. Giannini C, Diesse L, D'Adamo E et al. . Influence of the Mediterranean diet on carotid intima-media thickness in hypercholesterolaemic children: a 12-month intervention study. Nutr Metab Cardiovasc Dis 2014;24:75–82. 10.1016/j.numecd.2013.04.005
    1. Ellingsen I, Seljeflot I, Arnesen H et al. . Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study. Nutr Metab Cardiovasc Dis 2009;19:8–14. 10.1016/j.numecd.2008.01.006
    1. Sala-Vila A, Romero-Mamani ES, Gilabert R et al. . Changes in ultrasound-assessed carotid intima-media thickness and plaque with a Mediterranean diet: a substudy of the PREDIMED trial. Arterioscler Thromb Vasc Biol 2014;34:439–45. 10.1161/ATVBAHA.113.302327
    1. Petersen KS, Clifton PM, Keogh JB. The association between carotid intima media thickness and individual dietary components and patterns. Nutr Metab Cardiovasc Dis 2014;24:495–502. 10.1016/j.numecd.2013.10.024
    1. Ha V, Sievenpiper JL, de Souza RJ et al. . Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: a systematic review and meta-analysis of randomized controlled trials. CMAJ 2014;186:E252–62. 10.1503/cmaj.131727
    1. Jayalath VH, de Souza RJ, Sievenpiper JL et al. . Effect of dietary pulses on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Am J Hypertens 2014;27:56–64. 10.1093/ajh/hpt155
    1. Li SS, Kendall CW, de Souza RJ et al. . Dietary pulses, satiety and food intake: a systematic review and meta-analysis of acute feeding trials. Obesity (Silver Spring) 2014;22:1773–80. 10.1002/oby.20782
    1. He J, Whelton PK. Effect of dietary fiber and protein intake on blood pressure: a review of epidemiologic evidence. Clin Exp Hypertens 1999;21: 785–6.
    1. Lee YP, Puddey IB, Hodgson JM. Protein, fibre and blood pressure: potential benefit of legumes. Clin Exp Pharmacol Physiol 2008;35:473–6.
    1. Salehi-Abargouei A, Saraf-Bank S, Bellissimo N et al. . Effects of non-soy legume consumption on C-reactive protein: a systematic review and meta-analysis. Nutrition 2015;31:631–9. 10.1016/j.nut.2014.10.018
    1. Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: current imaging methods and new perspectives. Stroke 2005;36:2764–72. 10.1161/01.STR.0000190895.51934.43
    1. Rodríguez-Rejón AI, Castro-Quezada I, Ruano-Rodrígguez C et al. . Effect of a Mediterranean diet intervention on dietary glycemic load and dietary glycemic index: The PREDIMED Study. J Nutr Metab 2014;2014:985373 10.1155/2014/985373
    1. Mena MP, Sacanella E, Vazquez-Agell M et al. . Inhibition of circulating immune cell activation: a molecular antiinflammatory effect of the Mediterranean diet. Am J Clin Nutr 2009;89:248–56. 10.3945/ajcn.2008.26094
    1. Merchant AT, Kelemen LE, de Koning L et al. . Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis. Am J Clin Nutr 2008;87:168–74.
    1. Astrup A, Rice Bradley BH, Brenna JT et al. . Regular-fat dairy and human health: A synopsis of symposia presented in Europe and North America (2014–2015). Nutrients 2016;8:pii: E463 10.3390/nu8080463
    1. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK et al. . Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr 2011;93:158–71. 10.3945/ajcn.2010.29866
    1. Buil-Cosiales P, Irimia P, Ros E et al. . Dietary fibre intake is inversely associated with carotid intima-media thickness: a cross-sectional assessment in the PREDIMED study. Eur J Clin Nutr 2009;63:1213–9. 10.1038/ejcn.2009.45
    1. Satija A, Hu FB. Cardiovascular benefits of dietary fiber. Curr Atheroscler Rep 2012;14:505–14. 10.1007/s11883-012-0275-7
    1. Stanton RA. Nutrition problems in an obesogenic environment. Med J Aust 2006;184:76–9.
    1. Willett W. Nutritional Epidemiology. New York, NY: Oxford University Press, 1998.
    1. Zhang Y, Guallar E, Qiao Y et al. . Is carotid intima-media thickness as predictive as other noninvasive techniques for the detection of coronary artery disease? Arterioscler Thromb Vasc Biol 2014;34:1341–5. 10.1161/ATVBAHA.113.302075
    1. Duivenvoorden R, de Groot E, Elsen BM et al. . In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging. Circ Cardiovasc Imaging 2009;2:235–42. 10.1161/CIRCIMAGING.108.788059
    1. Harloff A, Zech T, Frydrychowicz A et al. . Carotid intima-media thickness and distensibility measured by MRI at 3 T versus high-resolution ultrasound. Eur Radiol 2009;19:1470–9. 10.1007/s00330-009-1295-8

Source: PubMed

3
Subscribe